GNS Healthcare and Alliance for Clinical Trials in Oncology Present Results of Causal Modeling that Identifies Clinical and Molecular Drivers of Survival in Colorectal Cancer Patients
Read more

* * * * * *

Precision Medicine Clinical Trial Releases New Findings: NCI-MATCH Data Strengthen Path Forward for Targeted Cancer Therapies
Read more

* * * * * *

GlycoMimetics Announces NCI-Sponsored Pivotal Trial of GMI-1271 in Older, Newly Diagnosed AML Patients Fit for Intensive Chemotherapy
Read more

* * * * * *

Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Demonstrate the Oncotype DX Breast Recurrence Score® Test Definitively Identifies the 70% of Women with Early-stage Breast Cancer Who Receive No Benefit from Chemotherapy, and the 30% of Women for Whom Chemotherapy Benefit Can be Life-saving
Read more

* * * * * *

Frontline Cabozantinib Approved in Europe for Advanced RCC
Read more

* * * * * *

AUA 2018: The Men’s Eating and Living (MEAL) Study: A Randomized Clinical Trial of a Diet Intervention in Men on Active Surveillance for Prostate Cancer
Read more | View video

* * * * * *

Surveillance Intensity Not Associated with Earlier Detection of Recurrence or Improved Survival in Colorectal Cancer Patients
Read more

* * * * * *

Following ACS Guidelines Shown to Improve Outcomes for Colon Cancer Survivors
Read more

* * * * * *

O'Reilly Discusses Status of Immunotherapy Research in Pancreas Cancer
Read more

* * * * * *

Publication: Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial
Van Blarigan EL, Fuchs CS, Niedzwiecki D, Zhang S, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, Ng K, Meyerhardt JA
JAMA Oncol. 2018 Jun 1;4(6):783-790. doi: 10.1001/jamaoncol.2018.0126.

 

 

For other articles in this issue of the Alliance E-News newsletter, see below.